US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.

Capitol-building-sunrise

The House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing highlighted two potential stumbling blocks in efforts to reform the regulatory system for cosmetic products in the US.

E&C Chair Frank Pallone, D-NJ, touched on both in his opening remarks at the hearing, titled “Building Consumer Confidence by...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America